Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 16, 2022 06:00 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman

Rob Davidson brings a deep understanding of CURE pipeline, provides expertise in continued new product development, patent creation and continuity in non-dilutive on-going deal transactions and years...
June 03, 2020 07:15 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary

OXNARD, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today a collaboration with PMI, a subsidiary of...
April 21, 2020 07:30 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339...
March 17, 2020 08:30 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction

OXNARD, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No....
February 12, 2020 07:15 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific

LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with...
February 05, 2020 17:21 ET | Source: Cure Pharmaceutical Holding Corp.

UPDATE – CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today by CURE Pharmaceutical (OTC: CURR), the company is updating this release to include forward looking statements. ...
February 05, 2020 07:15 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing...
December 05, 2019 07:00 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference

LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD...
November 14, 2019 07:00 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension

OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000...
October 09, 2019 07:25 ET | Source: Cure Pharmaceutical Holding Corp.

CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions

OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line...

Next Page keyboard_arrow_right